Seiboldt T, Zeiser C, Nguyen D, Celikyurekli S, Herter S, Najafi S
Br J Cancer. 2024; 131(4):763-777.
PMID: 38942989
PMC: 11333474.
DOI: 10.1038/s41416-024-02740-5.
Terrinoni A, Micheloni G, Moretti V, Caporali S, Bernardini S, Minieri M
Int J Mol Sci. 2023; 24(23).
PMID: 38069286
PMC: 10707059.
DOI: 10.3390/ijms242316962.
Qin N, Paisana E, Picard D, Leprivier G, Langini M, Custodia C
J Neurooncol. 2023; 165(2):329-342.
PMID: 37976029
PMC: 10689561.
DOI: 10.1007/s11060-023-04508-y.
Graziani V, Garcia A, Alcolado L, Le Guennec A, Henriksson M, Conte M
Sci Rep. 2023; 13(1):1273.
PMID: 36690651
PMC: 9870962.
DOI: 10.1038/s41598-023-27375-z.
Fahmy S, Dawoud A, Zeinelabdeen Y, Kiriacos C, Daniel K, Eltahtawy O
Cancers (Basel). 2022; 14(21).
PMID: 36358663
PMC: 9657918.
DOI: 10.3390/cancers14215244.
Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors.
Rivero-Hinojosa S, Grant M, Panigrahi A, Zhang H, Caisova V, Bollard C
Nat Commun. 2021; 12(1):6689.
PMID: 34795224
PMC: 8602676.
DOI: 10.1038/s41467-021-26936-y.
Multi-omics analysis of intertumoral heterogeneity within medulloblastoma uncharted-pathway subtypes.
Li Z, Wei Y, Shao Y, Tang L, Gong J
Brain Tumor Pathol. 2021; 38(3):234-242.
PMID: 34180021
DOI: 10.1007/s10014-021-00400-7.
The Protective Effects of Vitamins A and E on Titanium Dioxide Nanoparticles (nTiO2)-Induced Oxidative Stress in the Spleen Tissues of Male Wistar Rats.
Afshari-Kaveh M, Abbasalipourkabir R, Nourian A, Ziamajidi N
Biol Trace Elem Res. 2020; 199(10):3677-3687.
PMID: 33210191
DOI: 10.1007/s12011-020-02487-z.
CAR T Cell Therapy for Pediatric Brain Tumors.
Patterson J, Henson J, Breese R, Bielamowicz K, Rodriguez A
Front Oncol. 2020; 10:1582.
PMID: 32903405
PMC: 7435009.
DOI: 10.3389/fonc.2020.01582.
YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNA.
Kloetgen A, Duggimpudi S, Schuschel K, Hezaveh K, Picard D, Schaal H
Int J Mol Sci. 2020; 21(12).
PMID: 32585856
PMC: 7352269.
DOI: 10.3390/ijms21124453.
Homeoprotein OTX1 and OTX2 involvement in rat myenteric neuron adaptation after DNBS-induced colitis.
Bistoletti M, Micheloni G, Baranzini N, Bosi A, Conti A, Filpa V
PeerJ. 2020; 8:e8442.
PMID: 32095330
PMC: 7024580.
DOI: 10.7717/peerj.8442.
UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts.
Williams A, Garner E, Stafman L, Aye J, Quinn C, Marayati R
Transl Oncol. 2019; 12(10):1364-1374.
PMID: 31362265
PMC: 6664160.
DOI: 10.1016/j.tranon.2019.07.003.
Effects of vitamin A and vitamin E on attenuation of titanium dioxide nanoparticles-induced toxicity in the liver of male Wistar rats.
Moradi A, Ziamajidi N, Ghafourikhosroshahi A, Abbasalipourkabir R
Mol Biol Rep. 2019; 46(3):2919-2932.
PMID: 30887259
DOI: 10.1007/s11033-019-04752-4.
Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastoma.
Natsumeda M, Liu Y, Nakata S, Miyahara H, Hanaford A, Ahsan S
Neuropathology. 2019; 39(2):71-77.
PMID: 30632221
PMC: 8772614.
DOI: 10.1111/neup.12534.
UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
Garner E, Stafman L, Williams A, Aye J, Goolsby C, Atigadda V
J Neurooncol. 2018; 140(2):209-224.
PMID: 30132166
PMC: 6239946.
DOI: 10.1007/s11060-018-2950-1.
Otx2 promotes granule cell precursor proliferation and Shh-dependent medulloblastoma maintenance in vivo.
El Nagar S, Chakroun A, Le Greneur C, Figarella-Branger D, Di Meglio T, Lamonerie T
Oncogenesis. 2018; 7(8):60.
PMID: 30100614
PMC: 6087714.
DOI: 10.1038/s41389-018-0070-6.
INSM1 Expression Is Frequent in Primary Central Nervous System Neoplasms but Not in the Adult Brain Parenchyma.
Ames H, Rooper L, Laterra J, Eberhart C, Rodriguez F
J Neuropathol Exp Neurol. 2018; 77(5):374-382.
PMID: 29490065
PMC: 6019041.
DOI: 10.1093/jnen/nly014.
Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.
Stromecki M, Tatari N, Morrison L, Kaur R, Zagozewski J, Palidwor G
Mol Oncol. 2018; 12(4):495-513.
PMID: 29377567
PMC: 5891039.
DOI: 10.1002/1878-0261.12177.
Learning to see again: biological constraints on cortical plasticity and the implications for sight restoration technologies.
Beyeler M, Rokem A, Boynton G, Fine I
J Neural Eng. 2017; 14(5):051003.
PMID: 28612755
PMC: 5953572.
DOI: 10.1088/1741-2552/aa795e.
YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress.
Qu S, Sun Y, Li Y, Xu Z, Fu W
Cancer Med. 2017; 6(6):1389-1398.
PMID: 28485541
PMC: 5463081.
DOI: 10.1002/cam4.1073.